Archives

by in
Entry Author Date Location
Ziopharm Goes Lean to Stretch Funds for New Synthetic Biology Focus 04/09/13 New York
Cerulean Pharma Fails to Extend Lives in Lung Cancer Study 03/22/13 Boston
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Oncothyreon Cancer Drug Fails in Final Trial; Shares Tank 12/19/12 Seattle
Scarcity of Samples Threatens Personalized Medicine 07/23/12 National
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine 09/13/11 Boston
Allegro Gets Another $5.4M 07/07/11 Boston
Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment 07/05/11 Boston
Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine 05/18/11 San Francisco
Pfizer Lung Cancer Drug to Get Priority Review 05/17/11 New York
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
T2 Biosystems, On-Q-ity, and GnuBIO Report Progress in Hunting for Signs of Disease 04/07/11 Boston
Dana-Farber Scientists Leave Board of Startup in Legal Battle with Cancer Center 01/21/11 Boston
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients 12/10/10 Boston
Novartis Takes Aim at Bay-Area Biotech with Dana-Farber Roots in Legal Battle Over Potential Lung Cancer Drugs 12/02/10 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit 11/12/10 Boston
Dana-Farber and Bay-Area Startup File Responses in Lawsuit Over Rights to Cancer Molecule 11/10/10 Boston
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights 10/28/10 Boston
Merck Ends AVEO Collaboration 09/30/10 Boston
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News 07/29/10 Seattle
Integrated Diagnostics, Leroy Hood’s Latest Startup, Pockets $10M After Hitting Early Goals 07/22/10 Seattle
Oncothyreon’s Cancer Vaccine Back in the Saddle, as Merck KGaA Re-Starts Clinical Trials 06/17/10 Seattle
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News 05/28/10 Boston
Avila Therapeutics Strikes $209M Lung Cancer Deal with Clovis Oncology 05/25/10 Boston
Lee Hood’s Startup for Personalized Medicine, Integrated Diagnostics, Hires First CEO 03/29/10 Seattle
Merrimack Pharma Grabs $60M Upfront From Sanofi for Cancer Antibody 10/01/09 Boston
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.